Share on LinkedInShare on LinkedIn

ARTICLE · 02 JULY 2014

FDA Issues Draft Guidance Explaining Intent Not To Regulate "Low Risk" MDDS

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

In a draft guidance issued on June 20, FDA announced it does not intend to enforce compliance with regulations governing medical device data systems.

United StatesFood, Drugs, Healthcare, Life Sciences

In a draft guidance issued on June 20, FDA announced it does not intend to enforce compliance with regulations governing medical device data systems ("MDDS") and related devices, citing low risk and a desire to avoid unnecessary barriers to new digital health technologies. Although the guidance articulates a policy for digital health systems, it applies to a fairly narrow class of devices. FDA defines "MDDS" as "hardware or software products that transfer, store, convert formats, and display medical device data." Systems that modify or control the functions or parameters of a connected medical device fall outside the scope of this definition and thus may be subject to other regulatory controls, such as premarket review and certain postmarket requirements.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from